Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. lncRNA MEG3 restrained the M1 polarization of microglia in acute spinal cord injury through the HuR/A20/NF-κB axis

lncRNA MEG3 restrained the M1 polarization of microglia in acute spinal cord injury through the HuR/A20/NF-κB axis

Brain Pathology, 2022 · DOI: 10.1111/bpa.13070 · Published: January 1, 2022

Spinal Cord InjuryNeurologyGenetics

Simple Explanation

This study explores the role of lncRNA MEG3 in acute spinal cord injury (ASCI), focusing on its impact on microglia polarization and neuroinflammation. The research investigates how MEG3 affects the M1 polarization of microglia, which contributes to neuroinflammation in ASCI. The study found that lncRNA MEG3 expression is reduced in ASCI and that overexpressing MEG3 can restrain the M1 polarization of microglia, reducing neuroinflammation. This suggests that MEG3 has a protective role in ASCI by modulating the inflammatory response. Further investigation revealed that lncRNA MEG3 regulates microglia polarization through the HuR/A20/NF-κB axis, promoting motor function recovery and reducing neuroinflammation in mice with SCI. This identifies a specific molecular pathway through which MEG3 exerts its beneficial effects.

Study Duration
Not specified
Participants
36 patients with traumatic SCI, 36 healthy controls, 20 male C57BL/6 mice
Evidence Level
Not specified

Key Findings

  • 1
    LncRNA MEG3 expression is decreased in ASCI mouse spinal cord tissues and LPS-treated primary microglia and BV2 cells.
  • 2
    Overexpression of lncRNA MEG3 restrained the M1 polarization of microglia and neuroinflammation by regulating the NF-κB signaling pathway.
  • 3
    LncRNA MEG3 regulates the M1 polarization of microglia through the HuR/A20/NF-κB axis, boosting motor function recovery and neuroinflammation relief in mice with SCI.

Research Summary

This study investigates the role and mechanism of lncRNA MEG3 in the M1 polarization of microglia and neuroinflammation in acute spinal cord injury (ASCI). The findings demonstrate that lncRNA MEG3 expression is decreased in ASCI and that its overexpression can restrain the M1 polarization of microglia and neuroinflammation by regulating the NF-κB signaling pathway. The study further elucidates that lncRNA MEG3 regulates the M1 polarization of microglia through the HuR/A20/NF-κB axis, promoting motor function recovery and neuroinflammation relief in mice with SCI.

Practical Implications

Therapeutic Target

LncRNA MEG3 could be a potential therapeutic target for treating ASCI by modulating microglia polarization and reducing neuroinflammation.

Pathway Modulation

The HuR/A20/NF-κB axis is a critical pathway in ASCI, and understanding its regulation by lncRNA MEG3 can lead to new treatment strategies.

Biomarker Potential

LncRNA MEG3 levels in serum might serve as a biomarker for assessing the severity and progression of traumatic brain injury (TBI) and ASCI.

Study Limitations

  • 1
    The sample size of clinical samples is not sufficient.
  • 2
    Further studies are needed to expand clinical data.
  • 3
    The study needs more evidence-based conclusions.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury